vs

Side-by-side financial comparison of Vivos Therapeutics, Inc. (VVOS) and Worksport Ltd (WKSP). Click either name above to swap in a different company.

Worksport Ltd is the larger business by last-quarter revenue ($4.7M vs $3.8M, roughly 1.2× Vivos Therapeutics, Inc.). On growth, Worksport Ltd posted the faster year-over-year revenue change (62.0% vs 3.4%). Vivos Therapeutics, Inc. produced more free cash flow last quarter ($-5.3M vs $-6.3M). Over the past eight quarters, Worksport Ltd's revenue compounded faster (204.2% CAGR vs 5.8%).

Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks.

Worksport Ltd is a cleantech company specializing in portable solar energy solutions and custom truck bed accessories. Its core offerings include solar-powered tonneau covers for pickup trucks and portable mobile power stations, serving the North American automotive aftermarket and consumer clean energy segments.

VVOS vs WKSP — Head-to-Head

Bigger by revenue
WKSP
WKSP
1.2× larger
WKSP
$4.7M
$3.8M
VVOS
Growing faster (revenue YoY)
WKSP
WKSP
+58.6% gap
WKSP
62.0%
3.4%
VVOS
More free cash flow
VVOS
VVOS
$936.6K more FCF
VVOS
$-5.3M
$-6.3M
WKSP
Faster 2-yr revenue CAGR
WKSP
WKSP
Annualised
WKSP
204.2%
5.8%
VVOS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
VVOS
VVOS
WKSP
WKSP
Revenue
$3.8M
$4.7M
Net Profit
$-6.9M
Gross Margin
78.1%
30.1%
Operating Margin
-166.8%
-129.6%
Net Margin
-180.3%
Revenue YoY
3.4%
62.0%
Net Profit YoY
-143.8%
EPS (diluted)
$-0.58
$-0.65

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
VVOS
VVOS
WKSP
WKSP
Q4 25
$3.8M
$4.7M
Q3 25
$6.8M
$5.0M
Q2 25
$3.8M
$4.1M
Q1 25
$3.0M
$2.2M
Q4 24
$3.7M
$2.9M
Q3 24
$3.9M
$3.1M
Q2 24
$4.1M
$1.9M
Q1 24
$3.4M
$512.6K
Net Profit
VVOS
VVOS
WKSP
WKSP
Q4 25
$-6.9M
Q3 25
$-5.4M
$-4.9M
Q2 25
$-5.0M
$-3.7M
Q1 25
$-3.9M
$-4.5M
Q4 24
$-2.8M
Q3 24
$-2.6M
$-4.1M
Q2 24
$-1.9M
$-4.0M
Q1 24
$-3.8M
$-3.7M
Gross Margin
VVOS
VVOS
WKSP
WKSP
Q4 25
78.1%
30.1%
Q3 25
58.0%
31.3%
Q2 25
55.2%
26.4%
Q1 25
50.0%
17.7%
Q4 24
56.7%
11.1%
Q3 24
60.5%
7.9%
Q2 24
65.4%
15.4%
Q1 24
56.7%
7.3%
Operating Margin
VVOS
VVOS
WKSP
WKSP
Q4 25
-166.8%
-129.6%
Q3 25
-69.8%
-95.6%
Q2 25
-127.4%
-88.1%
Q1 25
-129.9%
-190.0%
Q4 24
-75.9%
-137.0%
Q3 24
-68.5%
-125.1%
Q2 24
-47.8%
-203.5%
Q1 24
-110.7%
-709.9%
Net Margin
VVOS
VVOS
WKSP
WKSP
Q4 25
-180.3%
Q3 25
-79.6%
-98.3%
Q2 25
-131.2%
-91.0%
Q1 25
-128.1%
-199.1%
Q4 24
-76.4%
Q3 24
-67.8%
-132.4%
Q2 24
-47.6%
-208.9%
Q1 24
-110.1%
-724.6%
EPS (diluted)
VVOS
VVOS
WKSP
WKSP
Q4 25
$-0.58
$-0.65
Q3 25
$-0.49
$-0.75
Q2 25
$-0.55
$-0.71
Q1 25
$-0.45
$-1.05
Q4 24
$0.41
$-1.14
Q3 24
$-0.40
$-1.40
Q2 24
$-0.60
$-1.55
Q1 24
$-1.63
$-1.75

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
VVOS
VVOS
WKSP
WKSP
Cash + ST InvestmentsLiquidity on hand
$2.0M
$5.9M
Total DebtLower is stronger
$2.9M
$2.7M
Stockholders' EquityBook value
$-1.5M
$22.9M
Total Assets
$25.2M
$30.7M
Debt / EquityLower = less leverage
0.12×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
VVOS
VVOS
WKSP
WKSP
Q4 25
$2.0M
$5.9M
Q3 25
$3.1M
$3.8M
Q2 25
$4.4M
$1.4M
Q1 25
$2.3M
$5.1M
Q4 24
$6.3M
$4.9M
Q3 24
$6.3M
$1.9M
Q2 24
$6.9M
$3.4M
Q1 24
$2.6M
$3.5M
Total Debt
VVOS
VVOS
WKSP
WKSP
Q4 25
$2.9M
$2.7M
Q3 25
$2.9M
Q2 25
$2.5M
Q1 25
$3.1M
Q4 24
$1.2M
$5.3M
Q3 24
$1.2M
Q2 24
$1.2M
Q1 24
Stockholders' Equity
VVOS
VVOS
WKSP
WKSP
Q4 25
$-1.5M
$22.9M
Q3 25
$2.5M
$19.8M
Q2 25
$4.6M
$17.3M
Q1 25
$4.4M
$20.1M
Q4 24
$8.0M
$17.4M
Q3 24
$7.7M
$16.4M
Q2 24
$6.3M
$19.1M
Q1 24
$582.0K
$18.9M
Total Assets
VVOS
VVOS
WKSP
WKSP
Q4 25
$25.2M
$30.7M
Q3 25
$25.6M
$27.0M
Q2 25
$26.0M
$23.6M
Q1 25
$11.3M
$26.7M
Q4 24
$15.3M
$25.7M
Q3 24
$15.3M
$24.9M
Q2 24
$15.8M
$27.2M
Q1 24
$11.8M
$27.3M
Debt / Equity
VVOS
VVOS
WKSP
WKSP
Q4 25
0.12×
Q3 25
0.15×
Q2 25
0.14×
Q1 25
0.16×
Q4 24
0.15×
0.30×
Q3 24
0.16×
Q2 24
0.19×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
VVOS
VVOS
WKSP
WKSP
Operating Cash FlowLast quarter
$-3.8M
$-6.1M
Free Cash FlowOCF − Capex
$-5.3M
$-6.3M
FCF MarginFCF / Revenue
-139.7%
-132.4%
Capex IntensityCapex / Revenue
40.0%
3.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-17.8M
$-18.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
VVOS
VVOS
WKSP
WKSP
Q4 25
$-3.8M
$-6.1M
Q3 25
$-4.2M
$-4.3M
Q2 25
$-3.5M
$-3.1M
Q1 25
$-3.8M
$-3.8M
Q4 24
$-2.9M
$-2.2M
Q3 24
$-4.2M
$-1.5M
Q2 24
$-3.0M
$-3.6M
Q1 24
$-2.5M
$-2.8M
Free Cash Flow
VVOS
VVOS
WKSP
WKSP
Q4 25
$-5.3M
$-6.3M
Q3 25
$-4.2M
$-4.6M
Q2 25
$-4.3M
$-3.2M
Q1 25
$-3.9M
$-4.0M
Q4 24
$-3.1M
$-2.2M
Q3 24
$-4.4M
$-1.7M
Q2 24
$-3.1M
$-3.7M
Q1 24
$-2.7M
$-3.0M
FCF Margin
VVOS
VVOS
WKSP
WKSP
Q4 25
-139.7%
-132.4%
Q3 25
-62.6%
-92.1%
Q2 25
-111.6%
-77.1%
Q1 25
-129.9%
-180.4%
Q4 24
-84.0%
-75.4%
Q3 24
-113.4%
-54.5%
Q2 24
-76.7%
-195.1%
Q1 24
-78.0%
-586.7%
Capex Intensity
VVOS
VVOS
WKSP
WKSP
Q4 25
40.0%
3.3%
Q3 25
1.2%
7.3%
Q2 25
20.2%
1.7%
Q1 25
4.0%
9.0%
Q4 24
4.5%
0.9%
Q3 24
5.0%
5.3%
Q2 24
1.5%
6.4%
Q1 24
4.4%
41.5%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

VVOS
VVOS

Services$3.2M84%
Products$594.0K16%

WKSP
WKSP

Segment breakdown not available.

Related Comparisons